Prescription drugs; prohibiting insurer from modifying coverage under certain conditions; providing civil penalty; promulgating rules. Effective date.
Second Reading referred to Health and Human Services
Summary
The bill bars Oklahoma health insurers from raising premiums, co‑pays, or moving a drug to a higher tier once the drug was pre‑authorized, the patient has received it, and the doctor keeps prescribing it. Exceptions exist if the FDA raises safety concerns or the manufacturer warns of a discontinuance. Violations would incur a civil penalty set by the Insurance Commissioner.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Topics
Track this bill
Get real-time alerts when SB 1306 changes status, plus AI-powered summaries and stage predictions.
Sign up free